GLP-1 drugs , or glucagon-like peptide-1 analogs , represent a substantial shift in how we handle diabetes mellitus . These new therapies work by mimicking the body’s own GLP-1 hormone , which supports https://bookmarkcork.com/story22536699/glp-1-a-significant-approach-in-diabetes-care